Global Surgical Stents Market Segmentation, By Type (Self-Expandable Stents and Balloon-Expandable Stents), Product (Vascular Stents and Non-Vascular Stents), Material (Standard Polymer, Metal, and Biodegradable Polymer), Application (Urinary Tract Diseases, Cardiac Diseases, and Others), End-Users (Clinics, Hospital, and Others) – Industry Trends and Forecast to 2032
Surgical Stents Market Analysis
The surgical stents market has seen significant growth due to the increasing prevalence of chronic diseases such as cardiovascular, respiratory, and urinary disorders. Stents are critical devices used to support and open blocked arteries or other bodily tubes during surgical procedures. The market is primarily driven by the rising aging population, the growing number of surgeries, and advancements in stent technology. Advancements in surgical stents have significantly improved their efficacy, safety, and patient outcomes. New-generation drug-eluting stents (DES), for instance, are designed to release medication that prevents restenosis (the re-narrowing of arteries), reducing the risk of complications. Biodegradable stents are another advancement, which dissolve over time, eliminating the need for a second procedure to remove them. Innovations in materials, such as the use of bioabsorbable polymers, have also improved stent performance, reducing adverse reactions and enhancing compatibility with the human body. The market faces challenges, including the high cost of advanced stents and risks associated with implantation, such as infection or thrombosis. Despite these challenges, ongoing research and the demand for minimally invasive procedures are expected to continue driving growth in the surgical stents market.
Surgical Stents Market Size
The global surgical stents market size was valued at USD 15.13 billion in 2024 and is projected to reach USD 26.10 billion by 2032, with a CAGR of 7.05% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Surgical Stents Market Trends
“Shift towards Biodegradable Stents”
The surgical stents market is experiencing significant growth, driven by advancements in minimally invasive procedures and the increasing adoption of drug-eluting stents (DES). A prominent trend in this market is the shift towards biodegradable stents, which are designed to dissolve over time, eliminating the need for a second surgery. These stents, made from materials such as bioabsorbable polymers, offer a more sustainable solution, reducing long-term risks such as restenosis (re-narrowing of arteries) and minimizing complications. For instance, the Absorb BVS (biodegradable vascular scaffold) from Abbott represents a breakthrough in the field, offering an alternative to traditional metal stents. As these biodegradable stents dissolve, they leave the artery free of a foreign object, lowering the risk of future complications and improving patient outcomes. This trend reflects the broader shift toward safer, more effective, and patient-friendly surgical solutions, making biodegradable stents a key area of focus for market growth and innovation.
Report Scope and Surgical Stents Market Segmentation
|
Attributes
|
Surgical Stents Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Resonetics (U.S.), ELLA – CS, s.r.o., Ltd (Czech Republic), Boston Scientific Corporation (U.S.), AMETEK Inc. (U.S.), Abbott (U.S.), ANGIOCARE B.V. (Netherlands), Meril Life Sciences Pvt. Ltd. (India), F. Hoffmann-La Roche Ltd (Switzerland), Elixir Medical (U.S.), Medtronic (Ireland), B. Braun SE (Germany), Amaranth Medical Analytics Pvt. Ltd. (India), and ART (U.S.)
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Surgical Stents Market Definition
Surgical stents are medical devices inserted into the body to support, widen, or hold open a hollow organ, duct, or blood vessel. They are commonly used in procedures for treating conditions such as arterial blockages, urinary obstructions, and respiratory issues. Stents are typically made from materials such as metal, plastic, or biodegradable polymers, and they are designed to remain in place for a prolonged period, allowing normal flow of blood, urine, or air.
Surgical Stents Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a major driver for the growth of the surgical stents market. As the global population ages, the incidence of chronic conditions such as cardiovascular diseases, urinary disorders, and respiratory conditions is rising, directly increasing the demand for stents. For instance, cardiovascular diseases (CVDs) are the leading cause of death worldwide, accounting for approximately 31% of global deaths, according to the World Health Organization (WHO). The rising number of patients with coronary artery disease (CAD), which requires stenting procedures such as angioplasty, is a significant contributor to market growth. In addition, the global prevalence of chronic obstructive pulmonary disease (COPD), which affects more than 250 million people worldwide, further drives the demand for stents, especially for airway and respiratory stenting. As the aging population increases, the need for stents to manage these chronic conditions is expected to continue growing, positioning the surgical stents market as a key component in the broader healthcare sector. This rise in chronic diseases underscores the growing reliance on stents, making it a critical market driver.
- Increasing Advancements in Minimally Invasive Procedures
Advancements in minimally invasive procedures have significantly contributed to the growth of the surgical stents market. The shift from traditional open surgeries to less invasive techniques, such as angioplasty for coronary artery disease and endoscopic procedures for gastrointestinal and urinary tract conditions, has led to an increased demand for stents. These procedures offer several advantages, including reduced risk of complications, shorter recovery times, and precise treatment. For instance, in coronary angioplasty, a drug-eluting stent (DES) is often used to open blocked arteries, allowing for better blood flow while minimizing the need for open-heart surgery. The use of endoscopic stents for conditions such as esophageal strictures or urinary obstructions has also become more prevalent, as they allow for less invasive treatment with fewer post-procedure complications. The rising preference for minimally invasive procedures, driven by improved patient outcomes and reduced hospital stays, is a key market driver, leading to the greater adoption of stents in various medical specialties.
Opportunities
- Increasing Technological Innovations in Stent Development
Technological innovations in stent development have created significant market opportunities, particularly with the advent of drug-eluting stents (DES) and biodegradable stents. DES, which are coated with medication that slowly releases to prevent restenosis (re-narrowing of arteries), have dramatically improved the safety and effectiveness of stenting procedures. For instance, the Cypher Stent from Cordis was one of the first drug-eluting stents to be introduced and showed a significant reduction in restenosis rates compared to bare-metal stents. In addition, the development of biodegradable stents, such as the Absorb BVS from Abbott, which dissolve over time, eliminating the need for a second procedure to remove the stent, is transforming the market. These innovations reduce long-term complications, improve patient outcomes, and reduce healthcare costs by eliminating the need for repeat interventions. As these technologies continue to evolve, they present significant opportunities for market expansion, attracting both established companies and new entrants to innovate and cater to growing patient needs, especially in cardiovascular and other stenting applications.
- Rising Global Healthcare Expenditures
Rising healthcare expenditures globally, especially in emerging markets, present a significant market opportunity for the surgical stents industry. As countries such as India, China, and Brazil experience economic growth, they are investing more in healthcare infrastructure, increasing access to advanced medical technologies, including stents. For instance, China's healthcare spending is projected to reach over USD 1 trillion by 2025, enabling wider adoption of drug-eluting stents (DES) and biodegradable stents, which were once limited to developed countries. As healthcare systems in emerging markets expand, patients are gaining access to more sophisticated treatments, driving demand for stents in treating cardiovascular diseases, urinary disorders, and other chronic conditions. This surge in healthcare spending enhances patient access to life-saving stenting procedures and creates a growing market for medical device manufacturers to introduce innovative stent technologies, fostering further market growth in these regions.
Restraints/Challenges
- High Cost of Stent Implantation
The high cost of stent implantation procedures remains a significant challenge in the surgical stents market, particularly in developed countries where advanced medical technologies are more readily available. For instance, the price of a coronary stent procedure can range from several thousand dollars in the U.S., making it financially burdensome for uninsured or underinsured patients. This cost barrier limits accessibility, especially for low-income individuals who may delay or forgo necessary treatment. In addition, while health insurance coverage can alleviate some financial strain, high deductibles and out-of-pocket expenses still pose obstacles for many patients. As a result, the affordability issue creates disparities in access to life-saving procedures, particularly in developing countries or underserved regions, ultimately hindering the widespread adoption of stent treatments and slowing market growth.
- Complications and Risks Associated
Complications and risks associated with stent procedures present a significant challenge to the surgical stents market. While stent implantation is generally considered safe, complications such as infection, thrombosis (blood clot formation), and restenosis (the re-narrowing of arteries) can occur, leading to adverse outcomes for patients. For instance, restenosis affects up to 30% of patients who receive traditional bare-metal stents, requiring additional interventions such as repeat procedures or prolonged medication. These potential risks can undermine patient confidence in stent procedures and may prompt healthcare professionals to seek alternative treatments, such as drug-eluting stents or non-invasive methods. Furthermore, the possibility of these complications increases healthcare costs, as patients may need extended hospital stays, follow-up treatments, or additional surgeries. The fear of negative outcomes associated with stent procedures may also deter some patients from opting for stent implants, slowing market adoption and growth.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Surgical Stents Market Scope
The market is segmented on the basis of type, product, material, application, and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Self-Expandable Stents
- Balloon-Expandable Stents
Product
- Vascular Stents
- Non-Vascular Stents
Material
- Standard Polymer
- Metal
- Biodegradable Polymer
Application
- Urinary Tract Diseases
- Cardiac Diseases
- Others
End-Users
- Clinics
- Hospitals
- Others
Surgical Stents Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, type, product, material, application, and end-users as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the surgical stents market, driven by the increasing prevalence of cardiovascular diseases and the growing aging population in the region. The high rate of heart-related health issues, combined with the expanding elderly demographic, is fueling the demand for stent procedures. In addition, advancements in medical technology and healthcare infrastructure have further contributed to the region's dominance. With a significant focus on improving cardiovascular health, North America is expected to continue to hold the largest market share in the surgical stents sector.
Asia-Pacific is anticipated to experience the highest growth in the surgical stents market, driven by the large patient population and rapidly expanding economies. As healthcare infrastructure improves and access to advanced medical treatments increases, the demand for surgical stents is rising. The growing prevalence of chronic diseases, such as cardiovascular conditions, along with a rising awareness of healthcare options, is contributing to this market expansion. With significant investments in healthcare innovation, Asia-Pacific is poised for substantial growth in the surgical stents sector.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Surgical Stents Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Surgical Stents Market Leaders Operating in the Market Are:
- Resonetics (U.S.)
- ELLA – CS, s.r.o., Ltd (Czech Republic)
- Boston Scientific Corporation (U.S.)
- AMETEK Inc. (U.S.)
- Abbott (U.S.)
- ANGIOCARE B.V. (Netherlands)
- Meril Life Sciences Pvt. Ltd. (India)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Elixir Medical (U.S.)
- Medtronic (Ireland)
- B. Braun SE (Germany)
- Amaranth Medical Analytics Pvt. Ltd. (India)
- ART (U.S.)
Latest Developments in Surgical Stents Market
- In June 2024, HonorHealth Research Institute became the first in the Southwest to implant a new stroke prevention stent. The patient underwent a non-surgical, catheter-based procedure involving this innovative stent, which works to remove blockages in neck arteries that could lead to a life-threatening stroke by depriving the brain of oxygen
- In March 2024, SafeGuard Surgical announced that its LeakGuard biodegradable stent received breakthrough device designation from the FDA. Along with this regulatory achievement, the company revealed the successful completion of its Series A funding round, with Tom Pepin, principal at Tapper Ventures, leading the investment. NFL quarterback Jameis Winston was also among the early investors in the company
SKU-